NIPAX

Serial Number 87127535
606

Registration Progress

Application Filed
Aug 4, 2016
Under Examination
Feb 7, 2017
Approved for Publication
Dec 13, 2016
Published for Opposition
Dec 13, 2016
Registered

Re-Apply for This Trademark

This trademark is no longer active. You may be able to file a new application for the same or similar mark.
Mark: NIPAX
Previous Owner: Glaxo Group Limited
Classes: 005

Trademark Image

NIPAX

Basic Information

Serial Number
87127535
Filing Date
August 4, 2016
Published for Opposition
December 13, 2016
Abandonment Date
September 11, 2017
Drawing Code
4000

Status Summary

Current Status
Inactive
Status Code
606
Status Date
Sep 11, 2017
Classes
005

Rights Holder

Glaxo Group Limited

99
Address
980 Great West Road
Brentford, Middlesex TW89GS

Ownership History

Glaxo Group Limited

Original Applicant
99
Brentford, Middlesex

Glaxo Group Limited

Owner at Publication
99
Brentford, Middlesex

Legal Representation

Attorney
Angela L. Wilson

USPTO Deadlines

No Upcoming Deadlines

No upcoming deadlines found for this trademark.

Application History

10 events
Date Code Type Description Documents
Sep 11, 2017 MAB6 O ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED Loading...
Sep 11, 2017 ABN6 S ABANDONMENT - NO USE STATEMENT FILED Loading...
Feb 7, 2017 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Dec 13, 2016 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Dec 13, 2016 PUBO A PUBLISHED FOR OPPOSITION Loading...
Nov 23, 2016 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Oct 31, 2016 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Oct 29, 2016 DOCK D ASSIGNED TO EXAMINER Loading...
Aug 9, 2016 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Aug 8, 2016 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders
First Use Anywhere: 0
First Use in Commerce: 0

Additional Information

Translation
The wording "NIPAX" has no meaning in a foreign language.

Classification

International Classes
005